Wednesday, February 10, 2010, 10:55pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Cornerstone Therapeutics Inc. (CRTX)

At 10:30PM SGT: 5.07 USD  Up 0.06 (1.20%)  
 MORE ON CRTX 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 Cornerstone Therapeutics Inc. (NCM:CRTX) Delayed quote dataEdit
Last Trade:5.07 USD
Trade Time:10:30PM SGT
Change:Up 0.06 (1.20%)
Prev Close:5.01
Open:5.02
Bid:5.07 x 100
Ask:5.14 x 100
1y Target Est:13.00
Day's Range:5.07 - 5.07
52wk Range:2.73 - 12.29
Volume:2,196
Avg Vol (3m):49,877.8
Market Cap:127.33M
P/E (ttm):7.27
EPS (ttm):0.70
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add CRTX to Portfolio   Download Data

 HEADLINES 
•Cornerstone Provides Guidance
Zacks.com (Mon, Jan 11)
•Cornerstone Therapeutics gives 2010 forecasts
AP (Thu, Jan 7)
•Cornerstone Therapeutics Provides 2010 Financial Guidance
PR Newswire (Thu, Jan 7)
•7 Stocks Attracting Top Investors
at Motley Fool (Thu, Jan 7)
•5 Top Stocks at Half Price
at Motley Fool (Wed, Dec 23)
•Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
PR Newswire (Sat, Dec 19)
•Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference
PR Newswire (Mon, Nov 23)
•Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
PR Newswire (Sat, Nov 21)
•Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
PR Newswire (Mon, Nov 16)
•CORNERSTONE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Nov 14)
•Cornerstone Therapeutics Appoints General Counsel
PR Newswire (Fri, Nov 13)
More Headlines for CRTX...
 ANALYST 
EPS Est (next year) (Dec-09) :0.34
EPS Est (in 2 years) (Dec-10) :0.01
Avg Rec (current)*:1.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Cornerstone Therapeutics Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for the respiratory market in the United States.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices